Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-13

Clinical Trial Update: A Research Study to Look at the Distribution and Effects of Coramitug on Amyloid Deposits in Heart Tissue Using PET/CT Imaging in People With ATTR Amyloidosis. [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating the distribution and effects of coramitug on amyloid deposits in heart tissue of people with transthyretin amyloid cardiomyopa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Coramitug (coramitug)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Transthyretin Amyloid Cardiomyopathy | Phase 1 | Status: RECRUITING